Galidesivir clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses galidesivir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses galidesivir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430CompletedPhase 1BioCryst PharmaceuticalsNCT03800173Written as galidesivir
- A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19TerminatedPhase 1BioCryst PharmaceuticalsNCT03891420Written as Galidesivir
- A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430CompletedPhase 1BioCryst PharmaceuticalsNCT02319772Written as BCX4430
Codes
What other systems call galidesivir · ClinicalTrials.gg INT005038
- MeSH (NLM) C517546galidesivirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) OLF97F86A7GALIDESIVIRConfirmed FDA, NLM
- NCI Thesaurus C172613GalidesivirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C517546 | galidesivir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | OLF97F86A7 | GALIDESIVIR | Confirmed FDA, NLM |
| NCI Thesaurus | C172613 | Galidesivir | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.